Tender Details

Country: USA
Summary: Vasculab GSX FDA K131860 Brand Name or Equal) Non-Invasive Physiologic Testing System
UST Ref No: 118548880
Deadline: 07 May 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: W81K0225QA037
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Description
This action is for the procurement Vasculab GSX FDA K131860 (Brand Name or Equal) Non-Invasive Physiologic Testing System.
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 and FAR Part 12 and 13, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested and a written solicitation will not be issued.
This is a request for quotation (RFQ) and the solicitation number is W81K0225QA037. This solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-05.
The North American Industry Classification System (NAICS) code for this acquisition is 339112, Surgical and Medical Instrument Manufacturing, with a small business size standard of 1,000 employees. The Product Service Code (PSC) is 6515, Medical Equipment and Accessories and Supplies.
Medical Readiness Contracting Office - Pacific intends to award a firm-fixed price purchase order resulting from this RFQ, on the basis of a quotation conforming to the solicitation and determined at a fair and reasonable price.
Offerors shall complete the line-item pricing structure below in addition to any provided quote material in company format. Typically, in accordance with FAR Part 29, the Federal Government is exempt from state and local sales taxes; however, the total contract price shall include any other non-exempt applicable federal, state, local taxes, or duties.
Delivery Date: 60 Days ADC (after date of contract award) FOB Point: Destination
Places of Delivery and Acceptance:
Madigan Army Medical Center, Joint Base Lewis McChord, Washington FAR Provision 52.212-1, Instructions to Offerors - Commercial Products and Commercial Services, applies to this acquisition. FAR Provision 52.212-2, Evaluation - Commercial ...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Vasculab GSX FDA K131860 Brand Name or Equal) Non-Invasive Physiologic Testing System - USA Tender

The DEPT OF DEFENSE | DEPT OF THE ARMY, a Government sector organization in USA, has announced a new tender for Vasculab GSX FDA K131860 Brand Name or Equal) Non-Invasive Physiologic Testing System. This tender is published on USARFP under UST Ref No: 118548880 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-07.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.